In this paper, a distributed adaptive finite-time consensus (FTC) control protocol for a high-order multi-agent system (MAS) with intermittent communications under switching topologies is proposed. Meanwhile, considering the problem of heterogeneous unknown nonlinearities and other uncertain disturbances, the adaptive neural network and the sliding mode control method are used to compensate the nonlinearity of each agent separately. The agents are homogeneous, so the system has symmetry. The switching topologies considered in this paper are asymmetric. Compared with consensus protocol for asymptotic convergence, simulation results show that the proposed method can effectively solve the presence of the nonlinear and accelerate the convergence speed of the system so that an FTC can be reached.
This paper studies the consensus problem of a second-order multiagent system (MAS) with fixed communication delay under the structure of leaderless and leader-following systems. By using graph theory and finite-time control scheme, a distributed control protocol is proposed for each agent to reach consensus in a finite time. In practical application, the time delay of states is unavoidable, and for this, the consensus method is supposed to be extended to solve the time-delay problem. Thus, a finite-time consensus protocol with communication time delay is proposed in this paper. Compared with the general consensus method, the reliability and convergence speed of the system are increased by using the finite-time control. In addition, the protocol is distributed, and all agents have only local interactions. Finally, the effectiveness of the proposed protocol is verified by two numerical simulations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.